The Use of Bifunctional NOP/Mu and NOP Receptor Selective Compounds for the Treatment of Pain, Drug Abuse, and Psychiatric Disorders

Lawrence Toll
  • Current Pharmaceutical Design, March 2013, Bentham Science Publishers
  • DOI: 10.2174/13816128113199990354
The author haven't finished explaining this publicationThe author haven't finished explaining this publication

The following have contributed to this page: Dr Lawrence Toll

In partnership with: